MARKETS 1h ago
Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore
Economic Times Stocks
Published 05 Nov 2026, 02:13 am IST
The company had posted a net profit of ₹1,260.9 crore in the corresponding period of the previous fiscal year, it said in a regulatory filing.
Revenue from operations rose 29.2% to ₹7,909.6 crore during the quarter from ₹6,123.2 crore a year earlier. Total expenses increased sharply to ₹6,806.6 crore during the quarter from ₹4,509 crore in the same period last year.
During the quarter, the pharmaceuticals business accounted for 83% of the company's sales, Zydus said in a statement.
Its India formulations business reported revenue of ₹1,884.4 crore, up 18% year-on-year, while the North America formulations business posted revenue of ₹3,314.5 crore.
Originally reported by Economic Times Stocks.Source: economictimes.indiatimes.com
Related reads
Livemint Markets · 19m
Gold ETFs fall 4% in a month ahead of Dhanteras 2026: Is this a buying opportunity? Experts weigh in
Economic Times Markets · 21m
Asian shares mostly advance following US midterms, though Kospi falls on selling of chipmakers
Livemint Markets · 29m
Bharti Airtel Q2 results 2026 today: Here's schedule, preview, expectations, returns; Should you buy ahead of earnings?
Livemint Markets · 42m
China’s Copper Squeeze Deepens as Buyers Scramble for Spot Metal